首页 文献索引 SCI期刊 AI助手
条件筛选
相关性 最新发表 最早发表
全文 标题 期刊 作者
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
模糊 精准
{{tag.shortname||tag.name}}:{{getFilterLabel(field)}} Clear All
Ulrik Korsgaard,Maria P Kristensen,Juan L García-Rodríguez et al. Ulrik Korsgaard et al.
The management of stage II colon cancer poses an important clinical challenge due to difficulties in identifying patients at risk of recurrence. RNA expression profiles in solid tissues have demonstrated a strong potential as prognostic mar...
Tanwei Yuan,Dominic Edelmann,Víctor Moreno et al. Tanwei Yuan et al.
Background: Tailoring surveillance and treatment strategies for stage II colon cancer (CC) after curative surgery remains challenging, and personalized approaches are lacking. We aimed to identify a gene methylation panel...
Maria Pihlmann Kristensen,Ulrik Korsgaard,Signe Timm et al. Maria Pihlmann Kristensen et al.
The tumor-stroma ratio (TSR) has shown prognostic value in various cancers, including colon cancer. This retrospective, multicenter cohort study aimed to investigate the prognostic value of TSR in a screened stage II colon cancer population...
Sameh Hany Emile,Nir Horesh,Zoe Garoufalia et al. Sameh Hany Emile et al.
Background: Current guidelines recommend selective adjuvant chemotherapy for stage II colon cancer with high-risk features. This study aimed to assess survival benefit of adjuvant chemotherapy in patients with stage II co...
Frank A Sinicrope Frank A Sinicrope
Rates of adjuvant chemotherapy in patients with early-onset versus later-onset stage II colon cancer.
B Brenner,K Shulman,A Hubert et al. B Brenner et al.
Background: The 12-gene Oncotype DX Colon Recurrence Score® result quantifies the recurrence risk in stage II/III colon cancer (CC). This real-world study investigated stage II CC patients whose treatment decisions incor...
Mehmet Zengin,Özlem Tanas Işıkçı Mehmet Zengin
Aim. Although it is now accepted in the literature that tumour budding (TB) is a useful survival indicator in colon cancer (CC), there are still uncertainties about daily use. Here we methodologically examined the role of TB on survival in ...
Yutong Lou,Lujing Yang,Shaojun Xu et al. Yutong Lou et al.
Purpose: To assess the prognostic value of three novel biomarkers, DNA ploidy, stroma-tumor fraction, and nucleotyping, seeking for more accurate stratification in stage II colon cancer. ...
Juliette Logeart,Thomas Samaille,Antoine Falcoz et al. Juliette Logeart et al.
Background: Stage II colon cancer (CC) exhibits considerable prognostic heterogeneous. Our objective was to assess survival but also the prognosis impact of microsatellite instability (MSI) in patients with stage IIC (T4b...
Soo Young Oh,Chan Wook Kim,Seonok Kim et al. Soo Young Oh et al.
Microabstract: This study evaluates the prognostic significance of obstructions in stage IIA colon cancer, distinguishing between partial and complete obstructions. It employs a retrospective review of 1914 patients with ...
耗时 0.32166 秒,为您在 48229835 条记录里面共找到 249 篇文章 [XML]